AGTPBP1
Basic information
Region (hg38): 9:85546539-85742029
Links
Phenotypes
GenCC
Source:
- neurodegeneration, childhood-onset, with cerebellar atrophy (Definitive), mode of inheritance: AR
- neurodegeneration, childhood-onset, with cerebellar atrophy (Strong), mode of inheritance: AR
- pontocerebellar hypoplasia type 1 (Supportive), mode of inheritance: AR
- neurodegeneration, childhood-onset, with cerebellar atrophy (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodegeneration, childhood-onset, with cerebellar atrophy | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 30420557 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (96 variants)
- Neurodegeneration,_childhood-onset,_with_cerebellar_atrophy (31 variants)
- not_provided (16 variants)
- AGTPBP1-related_disorder (12 variants)
- Aplasia/Hypoplasia_of_the_cerebellum (3 variants)
- Global_developmental_delay (3 variants)
- not_specified (2 variants)
- Neurodevelopmental_disorder_with_cerebellar_atrophy_and_with_or_without_seizures (2 variants)
- Motor_polyneuropathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGTPBP1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001330701.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 105 | 118 | ||||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
Total | 13 | 12 | 108 | 11 | 2 |
Highest pathogenic variant AF is 0.00000685855
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AGTPBP1 | protein_coding | protein_coding | ENST00000376083 | 25 | 195490 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.422 | 0.578 | 125709 | 0 | 37 | 125746 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.01 | 477 | 618 | 0.772 | 0.0000314 | 7799 |
Missense in Polyphen | 98 | 184.6 | 0.53089 | 2308 | ||
Synonymous | 0.527 | 208 | 218 | 0.955 | 0.0000113 | 2200 |
Loss of Function | 5.68 | 14 | 62.4 | 0.224 | 0.00000348 | 811 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000213 | 0.000211 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000151 | 0.000149 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.000237 | 0.000229 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of target proteins. Catalyzes the deglutamylation of polyglutamate side chains generated by post-translational polyglutamylation in proteins such as tubulins. Also removes gene-encoded polyglutamates from the carboxy-terminus of target proteins such as MYLK. Acts as a long-chain deglutamylase and specifically shortens long polyglutamate chains, while it is not able to remove the branching point glutamate, a process catalyzed by AGBL5/CCP5. {ECO:0000250|UniProtKB:Q641K1}.;
- Pathway
- Olfactory bulb development and olfactory learning;Post-translational protein modification;Metabolism of proteins;Carboxyterminal post-translational modifications of tubulin
(Consensus)
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- loftool
- 0.604
- rvis_EVS
- -1.08
- rvis_percentile_EVS
- 7.2
Haploinsufficiency Scores
- pHI
- 0.721
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.579
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.172
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Agtpbp1
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; muscle phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype;
Zebrafish Information Network
- Gene name
- agtpbp1
- Affected structure
- ventricular system
- Phenotype tag
- abnormal
- Phenotype quality
- edematous
Gene ontology
- Biological process
- eye photoreceptor cell differentiation;proteolysis;mitochondrion organization;cerebellar Purkinje cell differentiation;olfactory bulb development;C-terminal protein deglutamylation;protein side chain deglutamylation;neuromuscular process
- Cellular component
- nucleus;nucleolus;cytoplasm;mitochondrion;cytosol;intracellular membrane-bounded organelle
- Molecular function
- metallocarboxypeptidase activity;zinc ion binding;tubulin binding